Which prostate radiation is easier on patients? new trial aims to find out
NCT ID NCT03426748
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two radiation methods for men with low- or intermediate-risk prostate cancer: low dose rate (permanent seed implants) and high dose rate (temporary radioactive needles). The main goal is to see which approach better preserves urinary quality of life. About 140 men will be followed for up to 5 years to track side effects and recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (low dose rate or high dose rate brachytherapy)
What this could lead to
If this trial succeeds, it could show which brachytherapy method causes fewer urinary side effects while controlling prostate cancer equally well.
What could go wrong
This is an early-stage comparison with 140 participants, so results may not apply to all patients. Both treatments involve radiation risks like urinary or bowel problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
British Columbia Cancer Agency Center for the Southern Interior
Kelowna, British Columbia, V1Y5L3, Canada